BioSpace News Archive

Science 37 Holdings, Inc., the clinical research industry-leading Metasite™, announced that its Chief Delivery Officer, Darcy Forman, has been honored with a coveted spot on the prestigious PharmaVoice 100 list.

Corsair Pharma, Inc. today announced the closing of its $23M Series B financing led by New Rhein Healthcare Investors.

Tourmaline Bio, Inc. today announced the appointment of Gerhard Hagn, PharmD, to the newly created role of SVP, Head of Commercial and Business Development.

NewAmsterdam Pharma Company N.V. today announced that Michael Davidson, M.D., chief executive officer of NewAmsterdam Pharma, will participate in a fireside chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2023 at 1:50 p.m. ET.

Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that Dr. Andrew Goldstein, Daré Medical Advisor, will present at the 2023 Annual Meeting of The Menopause Society (formerly known as The North American Menopause Society, or NAMS) taking place September 27-30, 2023 at the Marriott Downtown in Philadelphia, PA.

Waters Corporation introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis.

Enveric Biosciences today announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,752,130, titled “Carboxylated Psilocybin Derivatives and Methods of Using,” pertaining to the Company’s EVM301 Series of molecules being developed as potential treatments for mental health disorders.

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) resubmission for TAK-721 (budesonide oral suspension) which is being investigated for the short-term treatment of eosinophilic esophagitis (EoE), a chronic inflammatory disease that can cause damage to the esophagus.

Sonendo, Inc. today announced that management will participate in the upcoming LD Micro Main Event XVI Conference. Management is scheduled to present on Wednesday, October 4th at 2:30 p.m. Pacific Time/ 5:30 p.m. Eastern Time.

Evaxion Biotech A/S today announced a collaboration with Afrigen Biologics (Afrigen).